Centers

EU-OPENSCREEN

Chulalongkorn University Drug Discovery and Drug Development Research Center (Chula4DR)

test

EU-OPENSCREEN is a multinational, not-for-profit initiative, which integrates high-capacity screening platforms and chemistry groups across Europe. The aim of this initiative is to support individual scientists interested in chemical biology...
Read more
Chulalongkorn Drug Discovery and Drug Development Research Center (Chula4DR) was established in 2017, with the aim to facilitate advancement of academic drug discovery and drug development research by leveraging innovations and sciences...
Read more

sfgd

Read more

Partnerships

Events

Jobs

Astra Zeneca and Broad Institute to Co-develop Antiviral and Antibacterial Drugs

Broad Institute and Astrza Zeneca have entered into a two year collaboration agreement to co-develop antiviral and antibacterial drugs. Screening and target hit to lead chemistry will take place at Broad while Astra Zeneca will be responsible for...

 
View all

Pharma and Academia Consortium Partner to Develop New Drugs in Europe

A consortium of academic institutes from Germany, Britain, Netherlands and Denmark partner with a group of leading pharmaceutical companies which include AstraZeneca, Sanofi, Bayer, UCB , Lundbeck , Merck KGaA, and Janssen which is a JNJ...

 
View all

Janssen Pharmaceuticals and Johns Hopkins To Develop New Therapies to Treat Neurological Diseases

Janssen Pharmaceuticals (Formerly OMJPI) a Johnson and Johnson entity has entered into collaboration agreement with Johns Hopkins Brain Science Institute ("BSi") at Johns Hopkins University. Janssen will be working with Johns Hopkins researchers...

 
View all

No EVENTS for listing

No Job Posts

Sponsors

Pfizer Roche HL Tocris Sigma-Aldrich Xenotech Xenotech Eurofins Pfizer Roche HL Tocris Sigma-Aldrich Xenotech Xenotech Eurofins
View All